REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
06/08/2026
Back to search
Official data from USPTO
PANBIO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
06/09/2026
Trademark type
Word
Nice classes
1, 5
Filing date
04/08/2020
Registration date
06/08/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/08/2021
Last transaction
06/09/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
79
Owner location
IE
Examiner
GUROK, GALINA
Law office
N80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Abbott Rapid Diagnostics International Subsidiary Unlimited Company
Representatives
Michele H. Bowman Abbott Laboratories
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Control preparations for in vitro diagnostic testingscreeningconfirmation and analysisdiagnostic preparations for scientific or research use; diagnostic reagents and chemical reagents for laboratory or research purposes; chemical reagentssolutions used in diagnostic test kits for laboratory or research purposes; chemically-treated nonmedical test strips for laboratory or research purposes for testing for respiratorycommunity acquiredhospital acquiredsexual healthgastro-entericvector borneblood borne pathogentropical disease infections; diagnostic test kits comprised of reagents for use in diagnostic tests for laboratory or research use; diagnostic preparations for laboratory or research use; diagnostic test kits comprising reagents and assays for laboratory or research use; in vitro diagnostic testschemical reagents and assays for testing for respiratorycommunity acquiredhospital acquiredsexual healthgastro-entericvector borneblood borne pathogentropical disease infections for laboratory or research useother than for medical or veterinary use; in vitro immunochromatographic testschemical reagents and assays for testing for respiratorycommunity acquiredhospital acquiredsexual healthgastro-entericvector borneblood borne pathogentropical disease infections for laboratory or research useother than for medical or veterinary use
Class 5
Diagnostic kits comprising medical diagnostic bioreagents for testing bloodbodily fluidnasal samplesoral samples and tissue for use in the detectionidentificationconfirmationmonitoring of respiratorycommunity acquiredhospital acquiredsexual healthgastro-entericvector borneblood borne pathogentropical disease infections; medical diagnostic test kits consisting primarily of monoclonal antibodiesbuffersreagents for use in disease testing; medical diagnostic test strips for testing bloodhuman serumplasmabodily fluidnasal swab specimensnasopharyngeal swab specimensoral specimensoropharyngeal swab specimenstissue for use in the detectionidentificationconfirmationmonitoring of respiratorycommunity acquiredhospital acquiredsexual healthgastro-entericvector borneblood borne pathogentropical disease infections; medical diagnostic reagents; diagnostic preparations for medical purposes; testing preparations for medical usediagnostic preparations; diagnostic tests for medical usemedical diagnostic test media in the form of stripscassettescartridgescards for the detectionidentificationconfirmationmonitoring of respiratorycommunity acquiredhospital acquiredsexual healthgastro-entericvector borneblood borne pathogentropical disease infections; medical diagnostic assays for testing of body fluidsbloodhuman serumplasmanasal swab specimensnasopharyngeal swab specimensoral specimensoropharyngeal swab specimenstissue; in vitro medical diagnostic testsmedical diagnostic test media in the form of stripscassettescartridgescards for the detectionidentificationconfirmationmonitoring of respiratorycommunity acquiredhospital acquiredsexual healthgastro-entericvector borneblood borne pathogentropical disease infections; in vitro medical diagnostic assays for testing of body fluidsbloodhuman serumplasmanasal swab specimensnasopharyngeal swab specimensoral specimensoropharyngeal swab specimenstissue; in vitro medical diagnostic test kits consisting primarily of monoclonal antibodiesbuffersreagents for use in disease testing; in vitro medical diagnostic test strips for use in the field of infectious disease; in vitro medical diagnostic reagents; in vitro immunochromatographic tests for medical usemedical diagnostic reagents and assays for testing of body fluidsbloodhuman serumplasmanasal swab specimensnasopharyngeal swab specimensoral specimensoropharyngeal swab specimenstissue; medical diagnostics tests for the detectiondiagnosisscreeningconfirmation of infectionsmedical diagnostic reagents and assays for testing of body fluidsbloodhuman serumplasmanasal swab specimensnasopharyngeal swab specimensoral specimensoropharyngeal swab specimenstissue
Publications
History of USPTO decisions and trademark events.
27 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/03/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/05/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/15/2021
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
09/28/2021
XXCR
GENERIC MADRID TRANSACTION CREATED
09/28/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/08/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
06/08/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/23/2021
PUBO
PUBLISHED FOR OPPOSITION
03/23/2021
GPNX
NOTIFICATION PROCESSED BY IB
03/21/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/03/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/03/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/03/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/16/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/09/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/08/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/08/2021
RFNT
REFUSAL PROCESSED BY IB
08/25/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/06/2020
RFRR
REFUSAL PROCESSED BY MPU
08/06/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/01/2020
CNRT
NON-FINAL ACTION WRITTEN
06/30/2020
DOCK
ASSIGNED TO EXAMINER
06/25/2020
MAFR
APPLICATION FILING RECEIPT MAILED
05/19/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/15/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/14/2020
Continuous trademark protection
Get notified about every new filing that threatens PANBIO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.